HEFT Repository

Idelalisib-Rituximab induces clinical remissions in patients with TP53 disrupted B cell prolymphocytic leukaemia.

Eyre, Toby A and Fox, Christopher P and Shankara, Paneesha and Went, Richard and Schuh, Anna H (2016) Idelalisib-Rituximab induces clinical remissions in patients with TP53 disrupted B cell prolymphocytic leukaemia. British journal of haematology. ISSN 1365-2141. This article is available to all HEFT staff and students via ASK HEFT Discovery tool http://tinyurl.com/z795c8c using their HEFT Athens Login.

Full text not available from this repository.
Official URL: http://onlinelibrary.wiley.com/doi/10.1111/bjh.140...
Item Type: Article
Additional Information: This article is available to all HEFT staff and students via ASK HEFT Discovery tool http://tinyurl.com/z795c8c using their HEFT Athens Login.
Subjects: WH Haemic and lymphatic systems. Haematology
Divisions: Planned IP Care > Oncology and Clinical Haematology
Related URLs:
Depositing User: Mr Philip O'Reilly
Date Deposited: 31 Mar 2017 13:37
Last Modified: 31 Mar 2017 13:37
URI: http://www.repository.heartofengland.nhs.uk/id/eprint/1343

Actions (login required)

View Item View Item